window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 10, 2026

  • News
  • About Us
Contact Us

ICH E6 R3

  • Clinical Development,Data Management,Technology and platforms

    Today Discover Pharma launches its annual 12 Days of Christmas campaign featuring CluePoints insight on RBQM

    The launch of the 12 Days of Christmas campaign marks [...]

    December 18, 2025
  • Clinical Development,Clinical Trials,Data Management,Patient Centricity,Real world evidence,Research & Development

    TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value

    A new collaborative study from TransCelerate BioPharma and the Tufts [...]

    September 22, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    How AI and risk-based models are shaping the future of clinical trials

    In this post-Clinical Trials Day spotlight, Ken McFarlane, VP of [...]

    May 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials
    Categories: Artificial Intelligence, Clinical Trials, Diagnostics, Oncology
  • DFE Pharma launches EcoLact 2030 to cut CO₂ emissions across lactose excipients
    Categories: Ingredients, Manufacturing, Pharmaceuticals and therapeutics, Sustainability
  • Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Respiratory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top